Our data show that G-CSF treatment can prevent progression of early DN in OLETF rats, and that mobilization of BM cells, rather than a direct effect of G-CSF, is the likely explanation for the observed effect. The gene discussed is CSF3; the disease is liver dysplastic nodule.